and to inhibit (l-3)-/?-glucan synthase activity of some yeasts and a few filamentous fungi5'8~21). In this paper, we examinethe nucleus and fatty acid components of cilofungin through in vitro susceptibility tests and in vitro inhibition ofglucan synthase of Neurospora crassa and Candida albicans. We report that the components of cilofungin alone do not exert antifungal or anti-glucan synthase activity. In addition, we show that echinocandin B, aculeacin A, and cilofungin differ in their abilities to inhibit glucan synthase activity in vitro. Glucose (250mCi/mmol) was purchased from ICN; cilofungin, echinocandin B nucleus and /7-octyloxybenzoic acid were obtained from Dr. C. J. Fouts-Johnson of Eli Lilly and
Company, Indianapolis, Indiana, U.S.A. Aculeacin A and echinocandin B were generous gifts of Toyo Jozo Co., Ltd., Tokyo, Japan, and Sandoz, Ltd., Basel, Switzerland, respectively. All enzymes and other chemicals were obtained from Sigma Chemical Co., St. Louis, Missouri, U.S.A. Distilled-deionized water was used throughout.
To determine the IC50 of various antifungal compounds, suspensions of N. crassa wild-type (74-OR8-la) macroconidia were prepared in Vogel's medium N22) plus sucrose 1.5% (w/v) from 5~7 days (25°C) slant cultures of agar-solidified Vogel's medium N plus sucrose 1.5% (w/v).
Suspensions were filtered through sterile cotton to exclude hyphal fragments and preconidial chains 433 and inoculated (1 x 104cells/ml) into Vogel's medium N plus sucrose 1.5% (w/v). Suspensions (100/zl) were aliquoted into sterile, round bottom 96-well microtiter plates (Corning).
In addition, slant cultures of C. albicans (B366, ATCC 56884), grown on Bacto-peptone (Difco) 1%, sucrose 4% (w/v) and agar 1.5% (w/v) for 5-7 days at 37°C, were flooded with 5 ml of Bacto-peptone 1% (w/v), sucrose 4% (w/v) and cells resuspended by mixing. The effects of cilofungin and its componentson N. crassa and C. albicans growth were determined and the results presented in Table 1 show that the APR. 1990 The C. albicans and N. crassa IC50 determinations were as described in the text. IC50 for C. albicans and N. crassa is highest dilution resulting in 50% inhibition of growth. Highest concentration of the fatty acid tested.
IC50 for cilofungin was 0.31 /zg/ml (N. crassa) and 0.078 jUg/ml (C. albicans), in agreement with previous results10). In sharp contrast, neither the nucleus nor the fatty acid alone or in combination showed significant antifungal activity. These results clearly indicate that the intact cilofungin molecule is necessary for inhibition of fungal growth.
Wealso tested the effect of cilofungin and its components on (l-3)-/?-glucan synthase activity of N. crassa and C. albicans. The results presented in Table 2 show that only intact cilofungin showed significant inhibition of glucan synthase activity. As was found for inhibition of fungal growth, neither the nucleus, nor the fatty acid, nor the two together had significant effect on enzyme activity. Thus, for inhibition of fungal growth and for inhibition of glucan synthase activity, the echinocandin B nucleus and the long chain fatty acid must be covalently bonded.
The effects of aculeacin A, echinocandin B, cilofungin, and its components on glucan synthase activity were tested more rigorously. The results in Table 3 show that the Kiapp for cilofungin was 7.5±0.5jum while that for the components were at least 100 times greater. Interestingly, the Aj£appfor cilofungin was lower than that of echinocandin B and aculeacin A. In addition, plots of 1/velocity vs.
1 /substrate for each inhibitor best fit noncompetitive inhibition (nomenclature of Cleland28)), (data not shown). These drugs share the same echinocandin B nucleus, but have different fatty acid side chains (see Fig. 1 andrefs 2, 3, 6-8, 10 and29) .
Our results show that for antifungal and anti-glucan synthase activity, the echinocandin B nucleus must be covalently bonded to a fatty acid side chain. Neither the nucleus nor the fatty acid a Protoplasts of C. albicans and N. crassa were isolated, lysed and (l-3)-jS-glucan synthase activity assayed as described in the text. Reaction mixtures contained UDP-[14C]glucose (TV. crassa: 1.2 mM, 30,000 cpm/assay; C. albicans: 2 mM, 60,000 cpm/assay), 1 50 //g cell protein, and the following concentrations of inhibitors: Cilofungin 30 jum, nucleus 300 /iM, fatty acid 150/jm, both nucleus 150^M and fatty acid 150 /iM. Reaction mixtures were incubated at 25°C for 0, 5, and 10 minutes for C. albicans and 0, 3, and 6 minutes for N. crassa and were terminated by the addition of 50 /il 5% (w/v) TCA. The incorporation of radioactive glucose into (l-3)-/?-D-glucan and velocities (nmol glucose per minute) were determined as described. + : standard deviation, N: 4 data points. b Reaction mixtures contained 4/zl 50% DMSO(control: "none") or 2ptl each of nucleus and fatty acid. These compounds contain the same echinocandin B nucleus but differ in their long chain fatty acids, Rt (aculeacin A, palmitic acid; echinocandin B, linoleic acid; cilofungin, /7-octyloxybenzoic acid). chain component has antifungal or anti-glucan synthase activity. In addition, our results clearly
show that the structure of the fatty acid chain is an important determinant in the potency of anti-glucan synthase activity. We suggest that analogues of cilofungin, altered in the fatty acid portion of the molecule, maybe even more potent inhibitors of glucan synthase and, hence, fungal growth. Reaction mixtures were incubated at 25°C for 0, 3, and 6 minutes, and the amounts of glucan formed determined as described. Data were processed and 
